RGEDF.US Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Healthcare Pharmaceuticals USA Stocks
41.60 USD
Close of Nov 17, 2026
27.61 43.76
Market cap
USD 7.59B
P/E
11.8x
P/B
1.85x
ROE
15.8%
Dividend yield
5.07%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is RGEDF.US undervalued?

Graham number
Price41.60
Graham value42.17
Discount1.3%

RGEDF.US trades 1.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt fundamental analysis

No fundamental analysis for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt yet.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-a…

Full company profile